首页 | 本学科首页   官方微博 | 高级检索  
检索        

树突状细胞体外诱导抗肝癌免疫抑制裸鼠人肝癌细胞系HepG2移植瘤发生与生长
引用本文:李明松,袁爱力,张亚历.树突状细胞体外诱导抗肝癌免疫抑制裸鼠人肝癌细胞系HepG2移植瘤发生与生长[J].中国肿瘤生物治疗杂志,1998,5(3):204-207.
作者姓名:李明松  袁爱力  张亚历
作者单位:第一军医大学南方医院消化科 广州510515
摘    要:为研究树突状细胞(DC)体外诱导抗肿瘤免疫能否预防裸鼠移植瘤发生及抑制裸鼠移植瘤生长,联合应用粒/巨噬细胞集落刺激因子(GM-CSF)及白介素4(IL-4)直接从肝癌患者外周血中培养出DC;以源于人肝癌细胞系HepG2的肿瘤抗原粗提物刺激DC,DC激活同源的T淋巴细胞;以被激活的T淋巴细胞预防性接种于裸鼠皮下,观察进一步接种的人肝癌细胞系HepG2移植瘤发生;观察被激活的T淋巴细胞抑制已接种于裸鼠的人肝癌细胞系HepG2移植瘤生长.发现,DC诱导的抗肿瘤免疫不仅能预防裸鼠人肝癌细胞系HepG2移植瘤发生,而且能抑制该移植瘤生长.提示经肿瘤抗原激活的DC作为一新概念上的抗肿瘤疫苗有可能在肝癌的预防及治疗中发挥重要作用.

关 键 词:树突状细胞  肝癌  肿瘤免疫  抗肿瘤疫苗
收稿时间:1997/11/10 0:00:00
修稿时间:1998/2/12 0:00:00

Immune Response Induced by Dendritic Cells Pulsed with Tumor Extracts in vivo Inhibit Growth of Implanted Tumor and Reject Challenge of Tumor Cells in Nudes
Li Mingsong,Yuan Aili and Zhang Yali.Immune Response Induced by Dendritic Cells Pulsed with Tumor Extracts in vivo Inhibit Growth of Implanted Tumor and Reject Challenge of Tumor Cells in Nudes[J].Chinese Journal of Cancer Biotherapy,1998,5(3):204-207.
Authors:Li Mingsong  Yuan Aili and Zhang Yali
Institution:Deptarment of Gastroenterology, Nanfang Hospital, First Military Medical University, Guangzhou 510515;Deptarment of Gastroenterology, Nanfang Hospital, First Military Medical University, Guangzhou 510515;Deptarment of Gastroenterology, Nanfang Hospital, First Military Medical University, Guangzhou 510515
Abstract:To study if the immune response in vivo induced by dendritic cells (DC) pulsed with tumor extract can inhibit the growth of implanted tumor and reject the challenge of tumor cells in nudes, we isolated and purified DC from hepato-cellcular cancer(HCC) patient with combination of granulocyte /macrophage colony stimulating factor and interleukin 4; extracted tumor-associated antigen from human hepatocellcular cancer cell line HepG2 tumor cells; initiated the T lymphocyte with DC pulsed by the TAA to product cytotoxic T lymphocyte (CTL); implanted the CTL to inhibit the growth of implanted tumor in nudes and protected the nudes against the further challenge of HepG2 tumor cells, and further found that the CTL induced by DC pulsed with TAA from HepG2 tumor cells can inhibit the growth of implanted tumor in nudes and protect the nudes against the further challenge of HepG2 tumor cells. The results suggest, as a new concept anti-tumor vaccine, DC pulsed by TAA may play an important role in therapy and prevent against tumor.
Keywords:dendritic cells  hepatocellcular carcinoma  tumor immunity  anti-tumor vaccine
本文献已被 CNKI 等数据库收录!
点击此处可从《中国肿瘤生物治疗杂志》浏览原始摘要信息
点击此处可从《中国肿瘤生物治疗杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号